N. Cichanowitz

11 papers receiving 614 citations

N. Cichanowitz's Hit Papers

Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials 2017 · 425 citations
4250+3+6Years since publication100200300400

Peers

N. Cichanowitz
Comparison fields: 5 of 60
  • Dermatology 197
  • Immunology 474
  • Rheumatology 69
  • Pathology and Forensic Medicine 62
  • Physiology 88
Replace Darío Kivelevitch with:
Darío Kivelevitch United States
S. D’Adamio Italy
Elisa Camela Italy
Deepak M.W. Balak Netherlands
C. Horreau France
Abby Jacobson United States
R. Jiménez‐Puya Spain
Amy Foulkes United Kingdom
M‐A Richard France
Canelle Mazaud France
N. Cichanowitz relative to Darío Kivelevitch United States Darío Kivelevitch's profile →
Citations per field
00.5×1.7×
Darío Kivelevitch · 1×
Citations per year

Countries citing papers authored by N. Cichanowitz

Since Specialization
Citations

This map shows the geographic impact of N. Cichanowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Cichanowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Cichanowitz more than expected).

Fields of papers citing papers by N. Cichanowitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Cichanowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Cichanowitz. The network helps show where N. Cichanowitz may publish in the future.

Co-authors

The 25 scholars most cited alongside N. Cichanowitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with N. Cichanowitz Line = papers co-authored together N. Cichanowitz links everyone, so they are left out of the graph.

All Works

11 of 11 papers shown
#Work
1
Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials
Hit paper breakdown →
2017425
2 201861
3 200749
4 200340
5 201925
6 201919
7 20184
8 20181
9
EFFECT OF TILDRAKIZUMAB ON PERSONAL RELATIONSHIPS IN PATIENTS WITH MODERATE-TO-SEVERE CHRONIC PLAQUE PSORIASIS
20181
10 20181
11 20181

About N. Cichanowitz

N. Cichanowitz is a scholar working on Immunology, Pathology and Forensic Medicine, Pediatrics, Perinatology and Child Health, Public Health, Environmental and Occupational Health and Pharmacology, having authored 11 papers that have together received 627 indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (8 papers), Pharmaceutical studies and practices (2 papers), Autoimmune Bullous Skin Diseases (2 papers), Parasites and Host Interactions (1 paper), Health Systems, Economic Evaluations, Quality of Life (1 paper), Menstrual Health and Disorders (1 paper), Immunodeficiency and Autoimmune Disorders (1 paper) and Research on Leishmaniasis Studies (1 paper). The work is most often cited by research in Dermatology (197 citations), Immunology (474 citations), Rheumatology (69 citations), Pathology and Forensic Medicine (62 citations) and Physiology (88 citations). N. Cichanowitz has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Kristian Reich, Andrew Blauvelt, Kim Papp, Carmen La Rosa, Alexa B. Kimball, Diamant Thaçi, Rodney Sinclair, Stephen K. Tyring, Kristine Nograles and Anish Mehta. Their work appears in journals such as Annals of the Rheumatic Diseases, British Journal of Dermatology, Journal of the European Academy of Dermatology and Venereology, Gynecologic and Obstetric Investigation and Osteoarthritis and Cartilage.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact